Literature DB >> 16102053

Molecular recognition mechanisms of thrombin.

J A Huntington1.   

Abstract

Thrombin is the final protease generated in the blood coagulation cascade, and is the only factor capable of cleaving fibrinogen to create a fibrin clot. Unlike every other coagulation protease, thrombin is composed solely of its serine protease domain, so that once formed it can diffuse freely to encounter a large number of potential substrates. Thus thrombin serves many functions in hemostasis through the specific cleavage of at least a dozen substrates. The solution of the crystal structure of thrombin some 15 years ago revealed a deep active site cleft and two adjacent basic exosites, and it was clear that thrombin must utilize these unique features in recognizing its substrates. Just how this occurs is still being investigated, but recent data from thrombin mutant libraries and crystal structures combine to paint the clearest picture to date of the molecular determinants of substrate recognition by thrombin. In almost all cases, both thrombin exosites are involved, either through direct interaction with the substrate protein or through indirect interaction with a third cofactor molecule. The purpose of this article is to summarize recent biochemical and structural data in order to provide insight into the thrombin molecular recognition events at the heart of hemostasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102053     DOI: 10.1111/j.1538-7836.2005.01363.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  73 in total

1.  Identification through combinatorial random and rational mutagenesis of a substrate-interacting exosite in the gamma domain of streptokinase.

Authors:  Suman Yadav; Rachna Aneja; Prakash Kumar; Manish Datt; Sonali Sinha; Girish Sahni
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

2.  Kinetics of protein-release by an aptamer-based DNA nanodevice.

Authors:  A Reuter; W U Dittmer; F C Simmel
Journal:  Eur Phys J E Soft Matter       Date:  2007-02-16       Impact factor: 1.890

3.  Stability and binding properties of a modified thrombin binding aptamer.

Authors:  Bruno Pagano; Luigi Martino; Antonio Randazzo; Concetta Giancola
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

4.  Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.

Authors:  Bon-Hun Koo; Jung Ho Han; Young Il Yeom; Doo-Sik Kim
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

5.  Interaction of thrombin with sucrose octasulfate.

Authors:  Bijoy J Desai; Rio S Boothello; Akul Y Mehta; J Neel Scarsdale; H Tonie Wright; Umesh R Desai
Journal:  Biochemistry       Date:  2011-07-18       Impact factor: 3.162

6.  A thrombin inhibitor from the gut of Boophilus microplus ticks.

Authors:  Clarisse Gravina Ricci; Antônio Frederico Michel Pinto; Markus Berger; Carlos Termignoni
Journal:  Exp Appl Acarol       Date:  2007-08-21       Impact factor: 2.132

7.  The role of thrombin exosites I and II in the activation of human coagulation factor V.

Authors:  Kenneth Segers; Björn Dahlbäck; Paul E Bock; Guido Tans; Jan Rosing; Gerry A F Nicolaes
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

8.  Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

9.  Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.

Authors:  David A Elliott; Glenda M Halliday; Brett Garner
Journal:  BMC Neurosci       Date:  2010-02-20       Impact factor: 3.288

10.  Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I.

Authors:  Ramya Billur; David Ban; T Michael Sabo; Muriel C Maurer
Journal:  Biochemistry       Date:  2017-11-21       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.